Literature DB >> 2785506

Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever.

B M Limson, R T Littaua.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785506     DOI: 10.1007/bf01646892

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  6 in total

1.  Antibiotic resistance in typhoid fever. Chloramphenicol resistance among clinical isolates of Salmonella typhosa in Los Angeles, 1972--epidemiologic and bacteriologic characteristics.

Authors:  G Overturf; K I Marton; A W Mathies
Journal:  N Engl J Med       Date:  1973-08-30       Impact factor: 91.245

2.  Treatment of multiresistant Salmonella typhi with oral ciprofloxacin.

Authors:  S J Eykyn; H Williams
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

3.  Treatment of Salmonella typhi carrier state with ciprofloxacin.

Authors:  S J Hudson; H R Ingham; M H Snow
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

4.  In vitro activity of ciprofloxacin (Bay o 9867).

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

5.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

6.  Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico.

Authors:  J Olarte; E Galindo
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

  6 in total
  9 in total

1.  Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.

Authors:  M Hussein Gasem; Monique Keuter; Wil M V Dolmans; Johanna Van Der Ven-Jongekrijg; Robert Djokomoeljanto; Jos W M Van Der Meer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Efficacy of the combination pivampicillin/pivmecillinam compared to placebo in the treatment of convalescent carriers of nontyphi Salmonella.

Authors:  B Svenungsson; E Ekwall; H B Hansson
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

3.  Comparison of two regimens for ciprofloxacin treatment of enteric infections.

Authors:  C Agalar; S Usubütün; E Tütüncü; R Türkyilmaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

Review 4.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

5.  Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.

Authors:  S Unal; M Hayran; S Tuncer; D Gür; O Uzun; M Akova; H E Akalin
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 6.  Quinolones in Salmonella typhi infection.

Authors:  H L DuPont
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 7.  Short course quinolone therapy of typhoid fever in developing countries.

Authors:  B M Limson
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 8.  The new quinolones in the treatment of diarrhoea and typhoid fever.

Authors:  A Waiz
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 9.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.